deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02060903

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

Sponsor: Accelovance

Conditions Head Lice Infestation
Interventions Abametapir Lotion 0.74% w/w Vehicle Lotion
Updated 9 times since 2017 Last updated: Sep 1, 2020 Started: Feb 28, 2014 Primary completion: Jul 31, 2014 Completion: Aug 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02060903, this PHASE3 trial focuses on Head Lice Infestation and remains completed. Sponsored by Accelovance, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshotCompleted~Jan 2019 – ~Jun 2020 · 17 months · monthly snapshotCompleted~Jun 2020 – ~Oct 2020 · 4 months · monthly snapshotCompleted~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jun 2020 — Oct 2020 [monthly]

    Completed PHASE3

▶ Show 4 earlier versions

  1. Jan 2019 — Jun 2020 [monthly]

    Completed PHASE3

  2. Jun 2018 — Jan 2019 [monthly]

    Completed PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Accelovance
  • Dr. Reddy's Laboratories Limited
  • Syneos Health
Data source: Dr. Reddy's Laboratories Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations